(Q40985918)

25 September 2017

1 reference

title

Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies (English)

1 reference

demyelinating polyneuropathy

25 September 2017

Guillain–Barré syndrome

0 references

1 reference

1

van der Meché FG

1 reference

25 September 2017

van Doorn PA

2

1 reference

25 September 2017

1 May 1995

1 reference

25 September 2017

1 reference

25 September 2017

37 Suppl 1

1 reference

25 September 2017

S14-31

1 reference

T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors

25 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370704

Elevated neopterin levels in Guillain-Barré syndrome. Further evidence of immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370704

Plasmapheresis in children with Guillain-Barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370704

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370704

Combination therapy of steroids and immunoglobulin in chronic refractory idiopathic thrombocytopenic purpura (ITP) enabling renal stone fragmentation by lithotripsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370704

Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370704

Chronic inflammatory demyelinating polyradiculoneuropathy: Comparison of patients with and without an associated monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370704

High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370704

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370704

Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370704

21 January 2018

Identifiers

DOI

10.1002/ANA.410370704

1 reference

25 September 2017

1 reference

PubMed ID

8968214